(WASHINGTON) – The American Society of Hematology (ASH) today announced that Bob Lӧwenberg, MD, PhD, Professor of Hematology at Erasmus University Medical School, Rotterdam, the Netherlands, will assume the role of editor-in-chief of Blood, the official journal of the Society, beginning in January 2013. Dr. Lӧwenberg, who was selected through an extensive search process, will be the first non-North-American editor-in-chief of the prestigious journal. He will succeed Cynthia E. Dunbar, MD, senior investigator at the National Institutes of Health (NIH) and head of the Molecular Hematopoiesis Section of the National Heart, Lung, and Blood Institute (NHLBI). Dr. Dunbar has served as Blood editor since January 2008.
“The Executive Committee was extremely impressed with the caliber of candidates presented for consideration by the search committee,” said ASH President J. Evan Sadler, MD, PhD, of the Washington University School of Medicine in St. Louis. “What most excited us about Dr. Lӧwenberg was his history of leadership and his vision for the future of Blood, which includes a unique global perspective, an emphasis on technology, and new ideas about presenting information in innovative, non-traditional ways.”
Dr. Lӧwenberg received his MD at Groningen University in 1971 and his PhD, cum laude, from Erasmus University. Between 1982 and 1990 he was scientific director of the Daniel den Hoed Cancer Center in Rotterdam, and between 1990 and 2011 he served as chair of the Department of Hematology at Erasmus University Medical Center. He has published approximately 700 papers in leading scientific journals and has served on the editorial boards of Blood, the New England Journal of Medicine, the Journal of Clinical Oncology, Leukemia, the British Journal of Haematology, and others.
Dr. Lӧwenberg’s research activities focus on experimental hematology, stem cell transplantation, and the treatment and pathology of leukemia.
“I consider the position of editor-in-chief of Blood to be an extraordinary honor, opportunity, and challenge,” said Dr. Lӧwenberg. “To the best of my ability I will devote my term as editor-in-chief to strengthening the already impressive reputation of Blood as the premier journal for publishing the best in basic, translational, and clinical hematology research and making the content more accessible to clinicians and our international readers.”
Reporters who wish to arrange an interview with Dr. Lӧwenberg may contact Andrea Slesinski at 202-776-0544 or email@example.com.
The American Society of Hematology is the world’s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online.
back to top